Prof Emma Duncan is Professor of Clinical Endocrinology at King’s College London, and Honorary Consultant, Department of Endocrinology, Guy’s and St Thomas’ NHS Foundation Trust.

After training in medicine at University of Sydney, she moved to the UK and undertook her doctorate in the genetics of osteoporosis at the Wellcome Trust Centre, University of Oxford, in collaboration with the Open University. Returning to Australia in 2005, Emma held professorial appointments at both University of Queensland and Queensland University of Technology and practised clinically as a at Princess Alexandra Hospital and Royal Brisbane and Women’s Hospital. In 2020 she moved back to the UK.

Since her undergraduate days Emma has been fascinated by endocrinology in general and bone in particular. Her basic research spans the genetics of many skeletal disorders, from common variant to rare monogenic disease gene discovery, and she has championed the translation of genetic technologies into clinical practice. Emma has also led many other projects in diabetes and endocrinology; and she is a clinical thought-leader in bone diseases internationally.

During the pandemic she established and led multiple studies in COVID-19, including studies of SARS-CoV-2 in children, the genetics of the post-COVID syndrome; and she co-created the COVID Symptom Study Biobank. As the pandemic subsides, she is enjoying returning to genomics, bone, and general endocrinology research; and she was recently awarded the European Calcified Tissues Society Kyowa Kirin Maria Luisa Bianchi Clinical Research Award for Rare Bone Diseases.

Emma contributes to leadership and governance nationally and internationally, and was recently voted president of the American Society for Bone and Mineral Research, in which role she will be promoting international basic and clinical research, and cooperation in musculoskeletal health globally.